Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus A Kuczyk

Showing results (11-20 of 209) with videos related to

Pageof 21
Sort By:
Expert Opinion on Investigational Drugs|August 7, 2014
Melanocortin receptor agonists in the treatment of male and female sexual dysfunctions: results from basic research and clinical studiesStefan Ückert, Andreas Bannowsky, Knut Albrecht, et al.
Health Science Reports|December 15, 2022
Expression and distribution of the transient receptor potential cationic channel ankyrin 1 (TRPA1) in the human seminal vesiclesHarrina E Rahardjo, Stefan Ückert, Markus A Kuczyk, et al.
European Urology|October 8, 2013
No androgen withdrawal syndrome for enzalutamide: a report of disease dynamics in the postchemotherapy settingChristoph A von Klot, Markus A Kuczyk, Axel S Merseburger
The Journal of Sexual Medicine|December 2, 2008
Effects of phosphodiesterase inhibitors on the contractile responses of isolated human seminal vesicle tissue to adrenergic stimulationStefan Uckert, Siamak Bazrafshan, Joachim E Sonnenberg, et al.
Molecular and Clinical Oncology|June 18, 2016
Novel therapeutic options for second-line therapy in metastatic renal cell carcinomaC A VON Klot, Axel S Merseburger, Markus A Kuczyk
Expert Review of Anticancer Therapy|June 22, 2012
Second-line systemic therapy for the treatment of metastatic renal cell cancerStephan Kruck, Jens Bedke, Markus A Kuczyk, et al.
Expert Review of Anticancer Therapy|October 16, 2009
Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancerAxel S Merseburger, Annika Simon, Sandra Waalkes, et al.
Urology|March 17, 2009
Effects of phosphodiesterase inhibitors on contraction induced by endothelin-1 of isolated human prostatic tissueGeorge T Kedia, Stefan Uckert, Merab Kedia, et al.
World Journal of Urology|September 7, 2002
The impact of extracorporal circulation on therapy-related mortality and long-term survival of patients with renal cell cancer and intracaval neoplastic extensionMarkus A Kuczyk, Torsten Münch, Stefan Machtens, et al.
BJU International|September 29, 2012
Arginase enzymes in the human prostate: expression of arginase isoenzymes and effects of arginase inhibitors on isolated human prostate tissueGeorge T Kedia, Joachim E Sonnenberg, Markus A Kuczyk, et al.
Pageof 21

Showing results (11-20 of 209) with videos related to

Sort By:
Pageof 21
Expert Opinion on Investigational Drugs|August 7, 2014
Melanocortin receptor agonists in the treatment of male and female sexual dysfunctions: results from basic research and clinical studiesStefan Ückert, Andreas Bannowsky, Knut Albrecht, et al.
Health Science Reports|December 15, 2022
Expression and distribution of the transient receptor potential cationic channel ankyrin 1 (TRPA1) in the human seminal vesiclesHarrina E Rahardjo, Stefan Ückert, Markus A Kuczyk, et al.
European Urology|October 8, 2013
No androgen withdrawal syndrome for enzalutamide: a report of disease dynamics in the postchemotherapy settingChristoph A von Klot, Markus A Kuczyk, Axel S Merseburger
The Journal of Sexual Medicine|December 2, 2008
Effects of phosphodiesterase inhibitors on the contractile responses of isolated human seminal vesicle tissue to adrenergic stimulationStefan Uckert, Siamak Bazrafshan, Joachim E Sonnenberg, et al.
Molecular and Clinical Oncology|June 18, 2016
Novel therapeutic options for second-line therapy in metastatic renal cell carcinomaC A VON Klot, Axel S Merseburger, Markus A Kuczyk
Expert Review of Anticancer Therapy|June 22, 2012
Second-line systemic therapy for the treatment of metastatic renal cell cancerStephan Kruck, Jens Bedke, Markus A Kuczyk, et al.
Expert Review of Anticancer Therapy|October 16, 2009
Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancerAxel S Merseburger, Annika Simon, Sandra Waalkes, et al.
Urology|March 17, 2009
Effects of phosphodiesterase inhibitors on contraction induced by endothelin-1 of isolated human prostatic tissueGeorge T Kedia, Stefan Uckert, Merab Kedia, et al.
World Journal of Urology|September 7, 2002
The impact of extracorporal circulation on therapy-related mortality and long-term survival of patients with renal cell cancer and intracaval neoplastic extensionMarkus A Kuczyk, Torsten Münch, Stefan Machtens, et al.
BJU International|September 29, 2012
Arginase enzymes in the human prostate: expression of arginase isoenzymes and effects of arginase inhibitors on isolated human prostate tissueGeorge T Kedia, Joachim E Sonnenberg, Markus A Kuczyk, et al.
Pageof 21